16 unknown. 16 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Unknown 16 |
| Phase 2 | 4 | Unknown 4 |
Follow Osteoporosis: new trials by email Literature Review of Osteoporosis trials Research Report on Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women SHR-2017 injection, Placebo - Osteoporosis | Phase 1 | Unknown | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 45 | 2023-07-04 | 2023-07-17 |
| TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density TST002 Injection, placebo - Osteoporosis | Phase 1 | Unknown | HJB (Hangzhou) Co., Ltd. | 32 | 2022-04-28 | 2022-05-26 |
| Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults HS-20090-2, Prolia - Postmenopausal Osteoporosis | Phase 1 | Unknown | Shanghai Hansoh Biomedical Co., Ltd | 174 | 2021-07-26 | 2021-08-25 |
| Study of NaQuinate in Healthy Volunteers NaQuinate, Placebo - Osteoporosis | Phase 1 | Unknown | Haoma Medica Limited | 58 | 2019-06-18 | 2019-07-30 |
| Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor Vivomixx, Placebo - Breast Cancer, Osteoporosis, Osteopenia | Phase 1 / Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 40 | 2019-01-01 | 2019-01-17 |
| G56W1 in Women With Postmenopausal Osteoporosis rhPTH（1-34） 28.2μg, rhPTH（1-34） 56.5μg, teriparatide acetate(Teribone™) - Postmenopausal Osteoporosis | Phase 1 / Phase 2 | Unknown | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 148 | 2018-10-01 | 2018-10-25 |
| A Clinical Trial to Evaluate the Safety and Pharmacokinetic HUG186-B and HUG186-D, HUG186 - Osteoporosis, Postmenopausal | Phase 1 | Unknown | Huons Co., Ltd. | 52 | 2018-01-11 | 2018-03-23 |
| Assessment of Anti-RANKL Antibody in Post-menopausal Women TK006 - Osteoporosis | Phase 1 | Unknown | Jiangsu T-Mab Biopharma Co.,Ltd | 24 | 2017-08-07 | 2018-03-14 |
| Effect of Blueberries on Bone Turnover Blueberry Baseline, Blueberry Low, Blueberry Medium - Osteoporosis, Postmenopausal, Bone Loss, Age-related | Phase 1 / Phase 2 | Unknown | Purdue University | 20 | 2017-01-12 | 2018-05-07 |
| Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease Epimedium Prenylflavonoids Extract, Placebo - Osteoporosis, Cardiovascular Disease | Phase 1 | Unknown | National University Hospital, Singapore | 30 | 2016-10-01 | 2016-10-14 |
| The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis Edirol - Osteoporosis | Phase 1 | Unknown | Shinshu University | 100 | 2014-12-01 | 2021-09-21 |
| Nasally and sc Administered Teriparatide in Healthy Volunteers Forsteo, CP046 PTH CriticalSorb - Osteoporosis | Phase 1 | Unknown | Nottingham University Hospitals NHS Trust | 7 | 2013-09-01 | 2013-08-01 |
| Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People Vitamin B12, folic acid, Vitamin D3, Placebo (Vitamin D3) - 600 IU per day - Osteoporosis, Cognitive Decline | Phase 1 | Unknown | Wageningen University | 3000 | 2008-09-01 | 2011-08-25 |
| Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis Gu-Sui-Bu (Davallia Divaricata) - Osteoporosis | Phase 1 | Unknown | National Taiwan University Hospital | 100 | 2002-01-01 | 2006-01-23 |
| Preventing Osteoporosis in Adolescent Girls Project FAB (Fitness and Bone) - Osteoporosis | Phase 1 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 250 | 2000-07-01 | 2005-06-24 |
| Bone Development in Adolescent Girls: Effects of Calcium and Exercise Calcium rich diet, Weight bearing exercise - Osteoporosis | Phase 1 / Phase 2 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 107 | 1998-05-01 | 2005-06-24 |
Osteoporosis, Postmenopausal (4) · Bone Diseases, Metabolic (2) · Bone Resorption (1) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Fractures, Bone (1) · Sedentary Behavior (1)
Bone Diseases (16) · Metabolic Diseases (16) · Musculoskeletal Diseases (16) · Nutritional and Metabolic Diseases (16) · Bone Diseases, Metabolic (14) · Behavior (1) · Breast Diseases (1) · Cognition Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Neurocognitive Disorders (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Cholecalciferol (1) · Denosumab (1) · Folic Acid (1) · Resistance Training (1) · Teriparatide (1) · Vitamin B 12 (1) · eldecalcitol (1) · gu-sui-bu (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · HJB (Hangzhou) Co., Ltd. (1) · Haoma Medica Limited (1) · Huons Co., Ltd. (1) · Jiangsu T-Mab Biopharma Co.,Ltd (1) · National Taiwan University Hospital (1) · National University Hospital, Singapore (1) · Nottingham University Hospitals NHS Trust (1) · Purdue University (1) · Shanghai Hansoh Biomedical Co., Ltd (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1) · Shinshu University (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1) · Tel-Aviv Sourasky Medical Center (1) · Wageningen University (1)
China (5) · United States (3) · United Kingdom (2) · Japan (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Connie M Weaver, PhD (1) · Dong Liu, PhD (1) · Eu Leong Yong, MD & PhD (1) · Jiang H Y (1) · Joan M. Lappe, Ph.D. (1) · Liu Hwa-Chang, Ph.D (1) · Margaret S. Jamner, PhD (1) · Muna Albayaty, MBChB (1) · Naftali Stern, M.D (1) · Tahir Masud, MRCP, FRCP (1) · Weibo Xia, Prof. (1) · Xiuhua Ren, Master (1) · Yukio Nakamura, MD, PhD (1)
PMID 22136481, PMID 26136594, PMID 26774115, PMID 30341095, PMID 35704085, PMID 36905458, PMID 37269909, PMID 42747328